<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-09-22T01:21:40Z</responseDate><request verb="GetRecord" identifier="oai:www.repository.cam.ac.uk:1810/287475" metadataPrefix="uketd_dc">https://api.repository.cam.ac.uk/server/oai/request</request><GetRecord><record><header><identifier>oai:www.repository.cam.ac.uk:1810/287475</identifier><datestamp>2021-04-21T19:15:33Z</datestamp><setSpec>com_1810_221925</setSpec><setSpec>com_1810_34581</setSpec><setSpec>col_1810_224160</setSpec></header><metadata><uketd_dc:uketddc xmlns:uketd_dc="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:uketdterms="http://naca.central.cranfield.ac.uk/ethos-oai/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://naca.central.cranfield.ac.uk/ethos-oai/2.0/ http://naca.central.cranfield.ac.uk/ethos-oai/2.0/uketd_dc.xsd">
   <dc:title>Characterising Heterogeneity of Glioblastoma using Multi-parametric Magnetic Resonance Imaging</dc:title>
   <dc:identifier xsi:type="dcterms:DOI">10.17863/CAM.34779</dc:identifier>
   <dc:creator>Li, Chao</dc:creator>
   <uketdterms:authoridentifier xsi:type="uketdterms:ORCID">0000000207340011</uketdterms:authoridentifier>
   <uketdterms:advisor>Price, Stephen John</uketdterms:advisor>
   <dcterms:abstract>A better understanding of tumour heterogeneity is central for accurate diagnosis, targeted therapy and personalised treatment of glioblastoma patients. This thesis aims to investigate whether pre-operative multi-parametric magnetic resonance imaging (MRI) can provide a useful tool for evaluating inter-tumoural and intra-tumoural heterogeneity of glioblastoma.
For this purpose, we explored: 1) the utilities of habitat imaging in combining multi-parametric MRI for identifying invasive sub-regions (I &amp; II); 2) the significance of integrating multi-parametric MRI, and extracting modality inter-dependence for patient stratification (III &amp; IV); 3) the value of advanced physiological MRI and radiomics approach in predicting epigenetic phenotypes (V). The following observations were made:
I.	Using a joint histogram analysis method, habitats with different diffusivity patterns were identified. A non-enhancing sub-region with decreased isotropic diffusion and increased anisotropic diffusion was associated with progression-free survival (PFS, hazard ratio [HR] = 1.08, P &lt; 0.001) and overall survival (OS, HR = 1.36, P &lt; 0.001) in multivariate models.
II.	Using a thresholding method, two low perfusion compartments were identified, which displayed hypoxic and pro-inflammatory microenvironment. Higher lactate in the low perfusion compartment with restricted diffusion was associated with a worse survival (PFS: HR = 2.995, P = 0.047; OS: HR = 4.974, P = 0.005).
III.	Using an unsupervised multi-view feature selection and late integration method, two patient subgroups were identified, which demonstrated distinct OS (P = 0.007) and PFS (P &lt; 0.001). Features selected by this approach showed significantly incremental prognostic value for 12-month OS (P = 0.049) and PFS (P = 0.022) than clinical factors. 
IV.	Using a method of unsupervised clustering via copula transform and discrete feature extraction, three patient subgroups were identified. The subtype demonstrating high inter-dependency of diffusion and perfusion displayed higher lactate than the other two subtypes (P = 0.016 and P = 0.044, respectively). Both subtypes of low and high inter-dependency showed worse PFS compared to the intermediate subtype (P = 0.046 and P = 0.009, respectively).
V.	Using a radiomics approach, advanced physiological images showed better performance than structural images for predicting O6-methylguanine-DNA methyltransferase (MGMT) methylation status. For predicting 12-month PFS, the model of radiomic features and clinical factors outperformed the model of MGMT methylation and clinical factors (P = 0.010).
In summary, pre-operative multi-parametric MRI shows potential for the non-invasive evaluation of glioblastoma heterogeneity, which could provide crucial information for patient care.</dcterms:abstract>
   <uketdterms:institution>University of Cambridge</uketdterms:institution>
   <dcterms:issued>2018-12-06</dcterms:issued>
   <dc:type>Thesis</dc:type>
   <uketdterms:qualificationlevel>Doctoral</uketdterms:qualificationlevel>
   <uketdterms:qualificationname>Doctor of Philosophy (PhD)</uketdterms:qualificationname>
   <dc:language>en</dc:language>
   <uketdterms:sponsor>The Cambridge Trust and China Scholarship Council ; Clare College; the British Neuro-Oncology Society; the EG Fearnsides Trust; the International Society for Magnetic Resonance in Medicine</uketdterms:sponsor>
   <dcterms:isReferencedBy xsi:type="dcterms:URI">https://www.repository.cam.ac.uk/handle/1810/287475</dcterms:isReferencedBy>
   <dc:identifier xsi:type="dcterms:URI">https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/d5dc6006-ec1d-4ac9-8111-9a70287137d8/download</dc:identifier>
   <uketdterms:checksum xsi:type="uketdterms:MD5">4362314445103f6c1ea9f5fc08230a3f</uketdterms:checksum>
   <dcterms:license>https://apollo8-f-pro.lib.cam.ac.uk/bitstreams/f9fc9c9e-6a1a-4f66-b6e4-86c15f32961e/download</dcterms:license>
   <uketdterms:checksum xsi:type="uketdterms:MD5">87eda9de84448d1f82354d60eee3eb5f</uketdterms:checksum>
   <dc:rights>https://www.rioxx.net/licenses/all-rights-reserved/</dc:rights>
   <dc:subject>magnetic resonance imaging</dc:subject>
   <dc:subject>diffusion imaging</dc:subject>
   <dc:subject>perfusion imaging</dc:subject>
   <dc:subject>magnetic resonance spectroscopy</dc:subject>
   <dc:subject>multiparametric MRI</dc:subject>
   <dc:subject>glioblastoma</dc:subject>
   <dc:subject>neuro-oncology</dc:subject>
   <dc:subject>tumour heterogeneity</dc:subject>
   <dc:subject>machine learning</dc:subject>
   <dc:subject>artificial intelligence</dc:subject>
   <dc:subject>radiogenomics</dc:subject>
   <dc:subject>radiomics</dc:subject>
   <dc:subject>tumour progression</dc:subject>
   <dc:subject>tumour evolution</dc:subject>
</uketd_dc:uketddc>
</metadata></record></GetRecord></OAI-PMH>